103 related articles for article (PubMed ID: 2668037)
1. Peri-operative blood transfusions in colorectal cancer.
Vente JP; Wiggers T; Weidema WF; Jeekel J; Obertop H
Eur J Surg Oncol; 1989 Aug; 15(4):371-4. PubMed ID: 2668037
[TBL] [Abstract][Full Text] [Related]
2. Blood transfusion and recurrence of colorectal cancer.
Modin S; Karlsson G; Wählby L; Wählby L
Eur J Surg; 1992; 158(6-7):371-5. PubMed ID: 1356471
[TBL] [Abstract][Full Text] [Related]
3. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
4. [Following curative resection of colorectal cancer, portal chemotherapy especially benefits non-transfused patients].
Harder F; Laffer U; Berres M; Jäggi P; Metzger U
Chirurg; 1990 Apr; 61(4):280-5. PubMed ID: 2112083
[TBL] [Abstract][Full Text] [Related]
5. [Effect of blood transfusions on the survival of patients with colorectal cancers].
Klingler K; Zhang X; Menghini T; Metzger U; Largiadèr F
Helv Chir Acta; 1989 Jan; 55(5):685-8. PubMed ID: 2715032
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.
Jahnson S; Andersson M
Eur J Surg; 1992 Aug; 158(8):419-25. PubMed ID: 1356481
[TBL] [Abstract][Full Text] [Related]
7. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
[TBL] [Abstract][Full Text] [Related]
8. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
9. The effect of preoperative blood transfusion on morbidity and survival in colorectal malignancy.
Nursal TZ; Hamaloğlu E
Turk J Gastroenterol; 2006 Dec; 17(4):283-7. PubMed ID: 17205407
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine as adjuvant treatment in colorectal cancer.
Nielsen HJ; Christensen IJ; Moesgaard F; Kehlet H;
Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
[TBL] [Abstract][Full Text] [Related]
11. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
Werther K; Christensen IJ; Nielsen HJ;
Eur J Surg; 2001 Apr; 167(4):287-92. PubMed ID: 11354321
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
13. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
15. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
16. [Effect of blood transfusion on tumor recurrence and rate of survival in colorectal cancer].
Wirsching RP; Demmel N; Liewald F; Mempel W; Zwingers N
Chirurg; 1988 Oct; 59(10):647-53. PubMed ID: 3197463
[TBL] [Abstract][Full Text] [Related]
17. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
19. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
20. [Effect of perioperative allogenic blood transfusion on prognosis of colorectal cancer].
Zimmermann T; Dobroschke J; Borowek U; Padberg W
Zentralbl Chir; 1991; 116(19):1125-38. PubMed ID: 1759510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
